Agadir – Relevant Moroccan authorities signed on February 4 an agreement aiming to develop the medical device industry in Morocco.
Minister of Health and Social Protection, Minister of Industry and Trade, the Director General of the Moroccan Agency for Medicines and Health Products, the head of the General Confederation of Moroccan Enterprises (CGEM), and the President of the Moroccan Federation of Health Industries (FMIS) signed the agreement during the second edition of “Medical Device Day.”
The event was organized by the FMIS, covering the period 2026-2030 to strengthen health and industrial autonomy in the country.
The initiative seeks to reduce Morocco’s reliance on imported medical devices, strengthen supply chain security, and support the development of a competitive, innovative, and sustainable local industry.
It also aims to improve workforce skills, attract industrial investment, and promote locally manufactured products.
The agreement is part of broader national health and industrial strategies designed to ensure fair, safe, and sustainable access to medical devices while maintaining high standards of quality, safety, and performance for products used in the national healthcare system.
Despite steady sector growth, Morocco still relies heavily on imports, which currently meet between 85% and 90% of national demand.
The agreement relies on coordinated action between public and private stakeholders, combining expertise, funding mechanisms, and operational tools.
Key measures include promoting local production to replace imports, supporting companies investing in medical device manufacturing through investment and export assistance programs, encouraging partnerships between Moroccan and international companies, and strengthening training programs to meet the sector’s skills needs.
Morocco’s efforts in developing the sector
Recent projects show ongoing efforts to expand care delivery capacity, which supports domestic medical and health-industry development. Authorities launched several healthcare centers in January, aiming to upgrade about 1,400 primary healthcare facilities nationwide, with a focus on accessibility, service quality, and patient care conditions.
Alongside infrastructure expansion, Morocco is deepening collaboration with global pharmaceutical and research actors.
Last month, the Mohammed VI Foundation for Sciences and Health and GSK Maroc signed a strategic agreement to strengthen biomedical research, therapeutic innovation, and medical practice improvement in Morocco
